Abstract:Objectives: Previous studies have confirmed a link between specific inflammatory cytokines and inflammatory bowel disease (IBD), but the causal relationship between them is not completely clear. This Mendelian Randomization (MR) study aims to evaluate the causal relationship between 18 inflammatory cytokines and inflammatory bowel disease. Method: Two-sample Mendelian randomization utilized genetic variances associated with IBD from two extensive publicly available genome-wide association studies (GWAS) (Crohn's Disease (CD): 12,194 cases and 28,072 controls; Ulcerative Colitis (UC): 12,336 cases and 33,609 controls). The data of inflammatory cytokines was acquired from a GWAS including 8,293 healthy participants. We used inverse variance weighted method, MR-Egger, weighted median, simple model and weighted model to evaluate the causal relationship between inflammatory cytokines and IBD. Sensitivity analysis includes heterogeneity and pleiotropy analysis to evaluate the robustness of the results. Results: The findings indicated suggestive positive associations between Interleukin-13 (IL-13) and macrophage migration inhibitory factor (MIF) with CD (odds ratio, OR: 1.101, 95%CI: 1.021-1.188, p = 0.013; OR: 1.134, 95%CI: 1.024-1.255, p = 0.015). IL-13 also displayed a significant positive correlation with UC (OR: 1.099, 95%CI: 1.018-1.186, p = 0.016). Stem cell factor (SCF) was suggested to be associated with the development of both CD and UC (OR: 1.032, 95%CI: 0.973-1.058, p = 0.012; OR: 1.038, 95%CI: 1.005-1.072, p = 0.024). Conclusion: This study proposes that IL-13 may be a factor correlated with the etiology of IBD (CD and UC), while MIF just be specifically associated with CD. Additionally, SCF appears more likely to be involved in the downstream development of IBD (CD and UC).

Updated Correlation Between Angiopoietic Factors and Inflammatory Bowel Disease

Inflammatory bowel disease and angiogenic factor

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease

Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta‐analysis

Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases

The emerging role of hypoxia and environmental factors in inflammatory bowel disease

The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease

New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease

Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease

Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery

Advances in research on the role of high carbohydrate diet in the process of inflammatory bowel disease (IBD)

Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)

The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease

[Research updates: the mechanism of autophagy in inflammatory bowel disease]

Inflammatory bowel disease and cardiovascular diseases: a concise review

Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease